BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32094154)

  • 1. Prospective community programme versus parent-driven care to prevent respiratory morbidity in children following hospitalisation with severe bronchiolitis or pneumonia.
    Byrnes CA; Trenholme A; Lawrence S; Aish H; Higham JA; Hoare K; Elborough A; McBride C; Le Comte L; McIntosh C; Chan Mow F; Jaksic M; Metcalfe R; Coomarasamy C; Leung W; Vogel A; Percival T; Mason H; Stewart J
    Thorax; 2020 Apr; 75(4):298-305. PubMed ID: 32094154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Respiratory health outcomes 1 year after admission with severe lower respiratory tract infection.
    Trenholme AA; Byrnes CA; McBride C; Lennon DR; Chan-Mow F; Vogel AM; Stewart JM; Percival T
    Pediatr Pulmonol; 2013 Aug; 48(8):772-9. PubMed ID: 22997178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HOspitalised Pneumonia Extended (HOPE) Study to reduce the long-term effects of childhood pneumonia: protocol for a multicentre, double-blind, parallel, superiority randomised controlled trial.
    Chang AB; Fong SM; Yeo TW; Ware RS; McCallum GB; Nathan AM; Ooi MH; de Bruyne J; Byrnes CA; Lee B; Nachiappan N; Saari N; Torzillo P; Smith-Vaughan H; Morris PS; Upham JW; Grimwood K
    BMJ Open; 2019 Apr; 9(4):e026411. PubMed ID: 31023759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for adverse outcomes of Indigenous infants hospitalized with bronchiolitis.
    McCallum GB; Chatfield MD; Morris PS; Chang AB
    Pediatr Pulmonol; 2016 Jun; 51(6):613-23. PubMed ID: 26575201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why do children hospitalised with pneumonia not receive antibiotics in primary care?
    Grant CC; Harnden A; Mant D; Emery D; Coster G
    Arch Dis Child; 2012 Jan; 97(1):21-7. PubMed ID: 22100740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Respiratory diseases in infants hospitalized during the 1st 2 years of life for viral lower respiratory tract infections: a one-year follow-up].
    Giovannini M; Rossi GA; Merolla R; Arena F; Cutrera R; Dalla Casa P; D'Andrea N; Galluzzo C; Indinnimeo L; Ivaldi M; Pifferi M; Rinaldi G; Torcoletti M; Zuccotti GV
    Minerva Pediatr; 2003 Apr; 55(2):149-55. PubMed ID: 12754459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respiratory sequelae and quality of life in children one-year after being admitted with a lower respiratory tract infection: A prospective cohort study from a developing country.
    Nathan AM; Teh CSJ; Eg KP; Jabar KA; Zaki R; Hng SY; Westerhout C; Thavagnanam S; de Bruyne JA
    Pediatr Pulmonol; 2020 Feb; 55(2):407-417. PubMed ID: 31846223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotics for persistent cough or wheeze following acute bronchiolitis in children.
    McCallum GB; Morris PS; Chang AB
    Cochrane Database Syst Rev; 2012 Dec; 12():CD009834. PubMed ID: 23235681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial.
    Valery PC; Morris PS; Byrnes CA; Grimwood K; Torzillo PJ; Bauert PA; Masters IB; Diaz A; McCallum GB; Mobberley C; Tjhung I; Hare KM; Ware RS; Chang AB
    Lancet Respir Med; 2013 Oct; 1(8):610-620. PubMed ID: 24461664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of a chronic cough management algorithm at the transitional stage from acute to chronic cough in children: a multicenter, nested, single-blind, randomised controlled trial.
    O'Grady KF; Grimwood K; Torzillo PJ; Rablin S; Lovie-Toon Y; Kaus M; Arnold D; Roberts J; Buntain H; Adsett D; King A; Scott M; Anderson J; Toombs M; Chang AB
    Lancet Child Adolesc Health; 2019 Dec; 3(12):889-898. PubMed ID: 31635952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of oral amoxicillin-clavulanate or azithromycin for non-severe respiratory exacerbations in children with bronchiectasis (BEST-1): a multicentre, three-arm, double-blind, randomised placebo-controlled trial.
    Goyal V; Grimwood K; Ware RS; Byrnes CA; Morris PS; Masters IB; McCallum GB; Binks MJ; Smith-Vaughan H; O'Grady KF; Champion A; Buntain HM; Schultz A; Chatfield M; Torzillo PJ; Chang AB
    Lancet Respir Med; 2019 Sep; 7(9):791-801. PubMed ID: 31427252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bronchiolitis of Infancy Discharge Study (BIDS): a multicentre, parallel-group, double-blind, randomised controlled, equivalence trial with economic evaluation.
    Cunningham S; Rodriguez A; Boyd KA; McIntosh E; Lewis SC;
    Health Technol Assess; 2015 Sep; 19(71):i-xxiii, 1-172. PubMed ID: 26364905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-resource use and quality of life in children with bronchiectasis: a multi-center pilot cohort study.
    Lovie-Toon YG; Grimwood K; Byrnes CA; Goyal V; Busch G; Masters IB; Marchant JM; Buntain H; O'Grady KF; Chang AB
    BMC Health Serv Res; 2019 Aug; 19(1):561. PubMed ID: 31409413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomised controlled trial evaluating the effectiveness and cost-effectiveness of 'Families for Health', a family-based childhood obesity treatment intervention delivered in a community setting for ages 6 to 11 years.
    Robertson W; Fleming J; Kamal A; Hamborg T; Khan KA; Griffiths F; Stewart-Brown S; Stallard N; Petrou S; Simkiss D; Harrison E; Kim SW; Thorogood M
    Health Technol Assess; 2017 Jan; 21(1):1-180. PubMed ID: 28059054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a clinical risk score for predicting drug-resistant bacterial pneumonia in older Chinese patients.
    Ma HM; Ip M; Woo J; Hui DS
    Respirology; 2014 May; 19(4):549-55. PubMed ID: 24661357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a clinical decision rule to guide antibiotic prescription in children with suspected lower respiratory tract infection in The Netherlands: A stepped-wedge cluster randomised trial.
    van de Maat JS; Peeters D; Nieboer D; van Wermeskerken AM; Smit FJ; Noordzij JG; Tramper-Stranders G; Driessen GJA; Obihara CC; Punt J; van der Lei J; Polinder S; Moll HA; Oostenbrink R
    PLoS Med; 2020 Jan; 17(1):e1003034. PubMed ID: 32004317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High incidence of pulmonary bacterial co-infection in children with severe respiratory syncytial virus (RSV) bronchiolitis.
    Thorburn K; Harigopal S; Reddy V; Taylor N; van Saene HK
    Thorax; 2006 Jul; 61(7):611-5. PubMed ID: 16537670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paediatric chronic suppurative lung disease: clinical characteristics and outcomes.
    Goyal V; Grimwood K; Marchant JM; Masters IB; Chang AB
    Eur J Pediatr; 2016 Aug; 175(8):1077-84. PubMed ID: 27287408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors in hospitalized community-acquired pneumonia: a retrospective study of a prospective observational cohort.
    Ito A; Ishida T; Tokumasu H; Washio Y; Yamazaki A; Ito Y; Tachibana H
    BMC Pulm Med; 2017 May; 17(1):78. PubMed ID: 28464807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Acute Illness Observation Scale (AIOS) in managing severe childhood pneumonia.
    Bharti B; Bharti S; Verma V
    Indian J Pediatr; 2007 Jan; 74(1):27-32. PubMed ID: 17264449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.